⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Chronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight
prnewswire.com
SNY
JSPR
IFRX
REGN
NVS
The Quest to Repair What Multiple Sclerosis Takes Away
globenewswire.com
QNTM
NVS
MRK
TGTX
BMY
Becoming rentABLE Joins Novartis' "SMAshing My Limits And Going Places" Campaign to Expand Accessible Lodging for People Living with SMA
prnewswire.com
NVS
Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer
globenewswire.com
ABBV
BMY
NVS
Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda
globenewswire.com
ABBV
ALNY
ASTL
AZN
BIIB
BMY
CSL
LLY
GILD
GSK
MRK
NVS
NVO
PFE
REGN
SNY
SUN
TEVA
UPST
VRTX
Women's Clinical Trials & CROs Market Forecast to More Than Double by 2036 as Precision Medicine Reshapes Trial Design
globenewswire.com
PFE
NVS
MRK
JNJ
Biond Biologics Appoints Giovanni Selvaggi, M.D., as Chief Medical Officer ("CMO")
prnewswire.com
BMY
NVS
GSK
Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
KODK
RKDA
OTLK
UTHR
CLSD
AZN
BTE
CCNE
IONS
APLS
GYRO
NVS
GNTX
BLTE
JNJ
LCTX
ABBV
REGN
New Ebook Reveals Why Most Companies Are Failing the Employees Who Stay After Restructuring
globenewswire.com
ABT
AMST
GM
KMB
LMT
NVS
SCL
Next Generation Drug Conjugates Market Expected to Reach USD 42.55 Billion by 2035 | MarketsandMarkets™
globenewswire.com
AZN
NVS
ALNY
GILD
ABBV
IONS
SNY